Prostate Cancer Care Before and After Medicare Eligibility
Marco D. Huesch MBBS, PhD, Michael K. Ong MD, PhD
Inquiry: The Journal of Health Care Organization, Provision, and Financing · 2016
doi:10.1177/0046958016647298 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Prior studies suggest Medicare eligibility confers significant and substantial reductions in mortality and beneficial increases in health service utilization. We compared 13 882 patients diagnosed with prostate cancer at ages 63 to 64 years with 14 774 patients diagnosed at ages 65 to 66 (controls) in 2004 to 2007. Compared with controls, patients diagnosed with prostate cancer before Medicare eligibility had no statistically significant or meaningful differences in cancer stage, time to treatment, or type of treatment.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.